Many viewers of the 2025 Golden Globes quickly noticed stars who seemed to have embraced GLP-1 medications that help people ...

Tirzepatide, a weekly GLP-1 and GIP drug, produced weight loss of up to 17.8% after 72 weeks. Semaglutide, a weekly GLP-1 ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Mitolyn announces its revolutionary purple peel exploit diet for weight loss by promoting mitochondrial efficiency and work. It follows a unique approach to make ...

From Nikki Glaser’s monologue and wins for “Emilia Pérez” and “The Brutalist,” it was downhill to all those pharmaceutical ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Seeking Alpha analyst Terry Chrisomalis regards Viking Therapeutics as the most attractive M&A candidate in 2025, bolstered ...

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

Columnist Glenn Whipp and staff writer Meredith Blake break down the best moments, top winners and biggest surprises of the ...